Aytu BioPharma posts updated investor presentation highlighting EXXUA opportunity

AYTU BIOPHARMA, INC

Presentation posted on June 17, 2025 for use in upcoming investor meetings.
Highlights EXXUA™ (gepirone) extended-release tablets as a key pipeline asset.
No new financial guidance, operational metrics, or material events disclosed.

item 7.01item 9.01

Source: SEC EDGAR

accession 0001437749-25-020579

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.